Showing results (111-120 of 147) with videos related to

Sort By:
Pageof 15
Leukemia Research|March 15, 2011
Characteristics and outcome of myelodysplastic syndromes (MDS) with isolated 20q deletion: a report on 62 casesThorsten Braun, Stéphane de Botton, Anne-Laure Taksin, et al.
The New England Journal of Medicine|September 15, 2016
Rituximab in B-Lineage Adult Acute Lymphoblastic LeukemiaSébastien Maury, Sylvie Chevret, Xavier Thomas, et al.
Clinical Rheumatology|January 22, 2019
Autologous haematopoietic stem cell transplantation (AHSCT) in autoimmune disease adult patients in France: analysis of the long-term outcome from the French Society for Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)Perrine Guillaume-Jugnot, Manuela Badoglio, Myriam Labopin, et al.
Blood|August 11, 2011
Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trialThorsten Braun, Raphael Itzykson, Aline Renneville, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2017
Postinduction Minimal Residual Disease Predicts Outcome and Benefit From Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia With NPM1 Mutation: A Study by the Acute Leukemia French Association GroupMarie Balsat, Aline Renneville, Xavier Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2013
Prognostic score including gene mutations in chronic myelomonocytic leukemiaRaphaël Itzykson, Olivier Kosmider, Aline Renneville, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|January 23, 2023
European guidelines on perinatal care: corticosteroids for women at risk of preterm birthGeorge Daskalakis, Vasilios Pergialiotis, Magnus Domellöf, et al.
Leukemia|January 30, 2020
Adult T-cell acute lymphoblastic leukemias with IL7R pathway mutations are slow-responders who do not benefit from allogeneic stem-cell transplantationRathana Kim, Nicolas Boissel, Aurore Touzart, et al.
The New England Journal of Medicine|June 3, 2025
Measurable Residual Disease-Guided Therapy in Newly Diagnosed MyelomaAurore Perrot, Jérôme Lambert, Cyrille Hulin, et al.
Blood|April 21, 2021
Prognostic significance of concurrent gene mutations in intensively treated patients with IDH-mutated AML: an ALFA studyMatthieu Duchmann, Jean-Baptiste Micol, Nicolas Duployez, et al.
Pageof 15